Objective: Our purpose was to investigate whether plasma lipid-soluble antioxidant levels during the third trimester of pregnancy and immediately after birth are altered in women with pregnancy-induced hypertension. Design: Nested case-control study of women with pregnancy-induced hypertension. Subjects: A group of 23 women with (mild) pregnancy-induced hypertension and their neonates, were compared with 23 matched controls with uncomplicated pregnancies. Methods: Concentrations of vitamin E isomers, several carotenoids, and retinol were determined by HPLC in venous plasma which had been stored for 2 ± 5 y. Antioxidant levels were adjusted for the degree of fatty acid unsaturation in plasma phospholipids as analysed 2 ± 5 y before. Results: In the third trimester of pregnancy, lipid-soluble antioxidant levels were similar in women with pregnancy-induced hypertension and controls. From the third trimester to postpartum, mean ( AEs.e.m.) b gtocopherol levels decreased by 0.38 AE0.17 mmolal or 5% (P 0.038) in the control group. In the pregnancyinduced hypertension group, however, plasma levels of most antioxidants decreased from the third trimester to postpartum, but only the decreases in plasma levels of b g-tocopherol of 1.08 AE0.27 mmolal or 26% (P 0.042), of a-tocopherol of 2.51 AE1.58 mmolal or 6% (P 0.024), and of lutein of 0.13 AE0.04 mmolal or 15% (P 0.013) reached statistical signi®cance as compared with the changes in the control group. At the same time, the polyunsaturated fatty acid unsaturation index of plasma phospholipids (UI) decreased in the pregnancyinduced hypertension group as well. Consequently, antioxidant levels, adjusted for UI, changed similarly in both groups. Umbilical vein plasma antioxidant levels were also similar after complicated and uncomplicated pregnancies. Conclusion: Plasma lipid-soluble antioxidant levels in mother and child are affected by mild pregnancy-induced hypertension, but this effect disappears after adjustment for fatty acid unsaturation.